Fukutin protein is expressed in neurons of the normal developing human brain but is reduced in Fukuyama‐type congenital muscular dystrophy brain

Fukuyama‐type congenital muscular dystrophy (FCMD) results from a mutation in a gene on chromosome 9q31, fukutin, and is characterized pathologically by micropolygyria of the cerebral and cerebellar cortices. To elucidate the physiological function of fukutin as well as its pathological role in FCMD, we raised antisera against fukutin protein and observed its expression in developing human brains with or without FCMD. Western blotting using these antibodies demonstrated a 60‐kd band in the fetal but not in postnatal cerebral cortex of the controls. This band appeared negligible in the brains of FCMD fetuses. Immunohistochemistry revealed the localization of fukutin in Cajal‐Retzius cells, the subpial granular layer, the neuropil of the marginal zone, the cortical plate neurons, and the ventricular neuroepithelium of the fetal cerebrum. In the fetal cerebellum, fukutin immunoreactivity was localized to the external granule cell layer, molecular layer, Purkinje cells, and some internal granular cells. The immunoreactivity in these structures was reduced markedly in postnatal normal brains, as well as in an FCMD cerebrum at 23 gestational weeks. The spatial and temporal pattern of fukutin expression is compatible with its predicted role: the regulation of neuronal migration in the fetal cerebrum and cerebellum. Ann Neurol 2000;47:756–764

[1]  Y. Tsutsui,et al.  Neuronal migration disorders in cerebral palsy , 1999, Neuropathology : official journal of the Japanese Society of Neuropathology.

[2]  E. Boncinelli,et al.  EMX2 protein in the developing mouse brain and olfactory area , 1998, Mechanisms of Development.

[3]  I. Kanazawa,et al.  An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy , 1998, Nature.

[4]  Miguel Marín-Padilla,et al.  Cajal–Retzius cells and the development of the neocortex , 1998, Trends in Neurosciences.

[5]  Y. Berwald‐Netter,et al.  A Novel CNS Gene Required for Neuronal Migration and Involved in X-Linked Subcortical Laminar Heterotopia and Lissencephaly Syndrome , 1998, Cell.

[6]  M. Frotscher.  Dual role of Cajal-Retzius cells and reelin in cortical development , 1997, Cell and Tissue Research.

[7]  M. Mizuguchi,et al.  Predominant Localization of the LIS Family of Gene Products to Cajal‐Retzius Cells and Ventricular Neuroepithelium in the Developing Human Cortex , 1997, Journal of neuropathology and experimental neurology.

[8]  V. Poukens,et al.  Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study , 1997, Acta Neuropathologica.

[9]  Kayoko Saito,et al.  Localization of laminin subunits in the central nervous system in Fukuyama congenital muscular dystrophy: an immunohistochemical investigation , 1997, Acta Neuropathologica.

[10]  C. Sotelo,et al.  Cajal-Retzius Cells Regulate the Radial Glia Phenotype in the Adult and Developing Cerebellum and Alter Granule Cell Migration , 1997, Neuron.

[11]  C. Shatz,et al.  Developmental changes revealed by immunohistochemical markers in human cerebral cortex. , 1996, Cerebral cortex.

[12]  A. Kakita,et al.  Lissencephaly gene product. Localization in the central nervous system and loss of immunoreactivity in Miller-Dieker syndrome. , 1995, The American journal of pathology.

[13]  M. Seike,et al.  The reeler gene-associated antigen on cajal-retzius neurons is a crucial molecule for laminar organization of cortical neurons , 1995, Neuron.

[14]  Y. Hayashizaki,et al.  The reeler gene encodes a protein with an EGF–like motif expressed by pioneer neurons , 1995, Nature Genetics.

[15]  T. Curran,et al.  A protein related to extracellular matrix proteins deleted in the mouse mutant reeler , 1995, Nature.

[16]  S. Thomas,et al.  Identification and characterization of the tuberous sclerosis gene on chromosome 16 , 1993, Cell.

[17]  G. Meyer,et al.  Developmental changes in layer I of the human neocortex during prenatal life: A DiI‐tracing and AChE and NADPH‐d histochemistry study , 1993, The Journal of comparative neurology.

[18]  D. Ledbetter,et al.  Isolation of a Miller–Dicker lissencephaly gene containing G protein β-subunit-like repeats , 1993, Nature.

[19]  A. Goffinet,et al.  The human transient subpial granular layer: An optical, immunohistochemical, and ultrastructural analysis , 1992, The Journal of comparative neurology.

[20]  H. Sarnat.  Role of human fetal ependyma. , 1992, Pediatric neurology.

[21]  Haruomi Nakamura,et al.  Cerebellar micropolygyria in fukuyama congenital muscular dystrophy: Observations in fetal and pediatric cases , 1990, Brain and Development.

[22]  S. Gould,et al.  The development of ependyma in the human fetal brain: an immunohistological and electron microscopic study. , 1990, Brain research. Developmental brain research.

[23]  U. Roessmann,et al.  Glial fibrillary acidic protein (GFAP) in ependymal cells during development. An immunocytochemical study , 1980, Brain Research.

[24]  L. Lapham,et al.  Evolution of Bergman glia in developing human fetal cerebellum: A Golgi, electron microscopic and immunofluorescent study , 1980, Brain Research.

[25]  S. Kamoshita,et al.  Congenital muscular dystrophy as a disease of the central nervous system. , 1976, Archives of neurology.

[26]  I. Nakano,et al.  Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? – Pathological study of the cerebral cortex of an FCDM fetus , 1996, Acta Neuropathologica.

[27]  A. Simeone,et al.  Germline mutations in the homeobox gene EMX2 in patients with severe schizencephaly , 1996, Nature Genetics.

[28]  R. Friede.  Gross and Microscopic Development of the Central Nervous System , 1989 .